<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154711</url>
  </required_header>
  <id_info>
    <org_study_id>819440</org_study_id>
    <nct_id>NCT02154711</nct_id>
  </id_info>
  <brief_title>Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease</brief_title>
  <official_title>Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to use a new research imaging technique, a kind of magnetic&#xD;
      resonance imaging (MRI), to measure important metabolic features of muscle, including&#xD;
      mitochondrial function, in people with mitochondrial disease and in healthy individuals.&#xD;
      (Mitochondria are tiny organelles that generate energy for the body.)&#xD;
&#xD;
      It is hoped that this new strategy will help physicians to understand better the health&#xD;
      problems of people with mitochondrial disease. Eventually, this could lead to better&#xD;
      diagnostic and treatment approaches.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are two study-related visits.&#xD;
&#xD;
      The first visit is a &quot;screening&quot; visit to ensure eligibility. This includes fasting blood&#xD;
      tests. The second visit is an MRI scanning session. This also takes around 2 - 3 hours, with&#xD;
      no more than 1.5 hours spent in the actual MRI machine. It may be possible to complete these&#xD;
      two visits on the same day. Otherwise, the MRI session should occur within 3 months of the&#xD;
      screening visit. In addition, an optional physical capacity visit will occur on the same day&#xD;
      as the MRI session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Creatine Recovery Time</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phosphocreatine recovery time</measure>
    <time_frame>15 minutes</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Mitochondrial Disease</condition>
  <arm_group>
    <arm_group_label>Mitochondrial Disease</arm_group_label>
    <description>Individuals with genetic diagnoses (nuclear or mitochondrial) of mitochondrial disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unaffected</arm_group_label>
    <description>Healthy individuals, without mitochondrial disease</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Two groups of subjects: 1) mitochondrial disease and 2) healthy individuals&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Group 1) Mitochondrial Disease:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Genetic diagnosis of mitochondrial disease&#xD;
&#xD;
          -  Be able to perform sub-maximal leg exercise for several minutes&#xD;
&#xD;
          -  Be able to provide written, informed consent&#xD;
&#xD;
          -  Cognitively and medically stable and able to comply with study procedures&#xD;
&#xD;
          -  Able to fast for 4 hours prior to blood draw and/or MRI scanning&#xD;
&#xD;
          -  Be willing to stop taking any over-the-counter vitamins and supplements that are&#xD;
             neither prescribed nor recommend by their physician for 2 weeks prior to MRI scanning&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Alcohol/substance abuse&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Use of any investigational agents within 4 weeks of enrollment&#xD;
&#xD;
          -  Any contraindication to MRI scanning&#xD;
&#xD;
        Group 2) Healthy Individuals:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Be able to perform sub-maximal leg exercise for several minutes&#xD;
&#xD;
          -  Be able to provide written, informed consent&#xD;
&#xD;
          -  Cognitively and medically stable and able to comply with study procedures&#xD;
&#xD;
          -  Able to fast for 4 hours prior to blood draw and/or MRI scanning&#xD;
&#xD;
          -  Be willing to stop taking any over-the-counter vitamins and supplements that are&#xD;
             neither prescribed nor recommend by their physician for 2 weeks prior to MRI scanning&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Carry a diagnosis of mitochondrial disease&#xD;
&#xD;
          -  Have a first-degree relative with a diagnosis of mitochondrial disease&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Alcohol/substance abuse&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Use of any investigational agents within 4 weeks of enrollment&#xD;
&#xD;
          -  Any contraindication to MRI scanning&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shana E McCormack, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 29, 2014</study_first_submitted>
  <study_first_submitted_qc>May 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>August 10, 2020</last_update_submitted>
  <last_update_submitted_qc>August 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Shana McCormack</investigator_full_name>
    <investigator_title>Instructor in Pediatrics</investigator_title>
  </responsible_party>
  <keyword>mitochondrial disease</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>magnetic resonance spectroscopy</keyword>
  <keyword>creatine</keyword>
  <keyword>phosphocreatine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitochondrial Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

